Do you want to read an article? Please log in or register.
Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies
ARDS
RECOMMENDED
Related content
RECOMMENDED
ARDSRespiratory Tract Infection
Pathogenesis of COVID-19-induced ARDS: implications for an aging population
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J.
Torres Acosta MA, Singer BD
doi: 10.1183/13993003.02049-2020.
RECOMMENDED
ARDS
Acute respiratory failure in COVID-19: is it "typical" ARDS?
Crit Care.
Li X, Ma X
doi: 10.1186/s13054-020-02911-9.
RECOMMENDED
ARDSRespiratory Tract Infection
Comparison of Hospitalized Patients with Acute Respiratory Distress Syndrome Caused by COVID-19 and H1N1
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
★ 2
Recommended by
Dr Martin Frey, Faculty Member
doi: 10.1016/j.chest.2020.03.032.
ARDS
COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Crit Care
Shi R, Lai C, Teboul JL, Dres M, Moretto F, De Vita N, Pham T, Bonny V, Mayaux J, Vaschetto R, Beurton A, Monnet X
doi: 10.1186/s13054-021-03594-6
RECOMMENDED
ARDS
COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Crit Care
Shi R, Lai C, Teboul JL, Dres M, Moretto F, De Vita N, Pham T, Bonny V, Mayaux J, Vaschetto R, Beurton A, Monnet X
doi: 10.1186/s13054-021-03594-6
RECOMMENDED
ARDS
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Schmidt M, Hajage D, Lebreton G, Monsel A, Voiriot G, Levy D, Baron E, Beurton A, Chommeloux J, Meng P, Nemlaghi S, Bay P, Leprince P, Demoule A, Guidet B, Constantin JM, Fartoukh M, Dres M, Combes A, Groupe de Recherche Clinique en REanimation et Soins intensifs du Patient en Insuffisance Respiratoire aiguE (GRC-RESPIRE) Sorbonne Université., Paris-Sorbonne ECMO-COVID investigators.
doi: 10.1016/S2213-2600(20)30328-3.
ARDS
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
Crit Care.
Menzella F, Fontana M, Salvarani C, Massari M, Ruggiero P, Scelfo C, Barbieri C, Castagnetti C, Catellani C, Gibellini G, Falco F, Ghidoni G, Livrieri F, Montanari G, Casalini E, Piro R, Mancuso P, Ghidorsi L, Facciolongo N
doi: 10.1186/s13054-020-03306-6.
RECOMMENDED
ARDS
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
JAMA.
Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, Avezum A, Lopes RD, Bueno FR, Silva MVAO, Baldassare FP, Costa ELV, Moura RAB, Honorato MO, Costa AN, Damiani LP, Lisboa T, Kawano-Dourado L, Zampieri FG, Olivato GB, Righy C, Amendola CP, Roepke RML, Freitas DHM, Forte DN, Freitas FGR, Fernandes CCF, Melro LMG, Junior GFS, Morais DC, Zung S, Machado FR, Azevedo LCP, COALITION COVID-19 Brazil III Investigators
doi: 10.1001/jama.2020.17021.
PHARMA NEWS
Respiratory Tract InfectionFurther Publications